EMA Assessing 'Slightly' Raised Heart Attack Risk With Two COVID-19 Vaccines

Moderna's Spikevax Linked To Flare-Up Of Capillary Leak Syndrome

The EU’s latest safety report on coronavirus vaccines looks at the risk of myocardial infarction, pulmonary embolism, thrombosis and capillary leak syndrome following vaccination.

The concept of a coronavirus vaccine. syringe and covid-19 virus on a white background
The safety of COVID-19 vaccines is kept under constant surveillance • Source: Alamy

The European Medicines Agency’s pharmacovigilance risk assessment committee (PRAC) has begun evaluating reports of myocardial infarction following the administration of two coronavirus vaccines, COVID-19 Vaccine Janssen and AstraZeneca PLC/Oxford University’s Vaxzevria. Reports of pulmonary embolism and thromboses with Vaxzevria are also being investigated.

The EMA said PRAC was aware of the results of an epidemiological study based on French national databases and posted...

More from Vaccines

More from Pink Sheet

Industry Criticizes Dutch Decision To Slash PARP Inhibitor Reimbursement

 

ZIN, the Dutch health technology assessment body, estimates that the number of patients eligible for treatment with a PARP inhibitor will be halved following a reassessment of drugs in the class.

EU Biosimilar Filings, Opinions And Approvals

 

A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.

US FDA’s ADHD Drug Relabeling Advances A MAHA Priority, Reviving Data Dispute

 

Extended-release stimulants will add a new ‘Limitation of Use’ about weight loss in children under 6 years, reflecting concerns about overuse from the Make America Healthy Again commission, a concern multiple studies did not find valid.